Screener
Ionis Pharmaceuticals IONS Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Depreciation | 6,734 | 4,494 |
| Amortization of right-of-use operating lease assets | 6,990 | 5,177 |
| Amortization of other assets | 1,361 | 1,180 |
| Amortization of discount on investments, net | (9,533) | (12,978) |
| Amortization of debt issuance costs | 4,150 | 3,288 |
| Non-cash royalty revenue related to sale of royalties | (22,387) | (24,894) |
| Non-cash interest related to sale of future royalties | 34,538 | 37,165 |
| Stock-based compensation expense | 88,870 | 59,408 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments?
- Ionis Pharmaceuticals (IONS) reported accretion (amortization) of discounts and premiums, investments of $3.34M in Q2 2026.
- How has Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments decreased by 43.0% year-over-year, from $5.87M to $3.34M.
- What is the long-term trend for Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments has grown at a 10.1% compound annual growth rate (CAGR), from -$17.78M to $23.74M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- The non-cash adjustment to the carrying value of investment securities, reflecting the amortization of premiums or accretion of discounts over the life of the investment. This ensures the effective interest rate is reflected in the income statement.
Ask your AI about Ionis Pharmaceuticals's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude